Lisa Schnirring | News Editor | CIDRAP NewsOct 16, 2020As the next steps, officials will conduct a meta-analysis of remdesivir studies, which experts will use to guide their latest treatment advice.
Large trial shows little benefit for remdesivir, pandemic total tops 39 million
More from COVID-19More posts in COVID-19 »
- Moderna reports promising findings for next-generation COVID vaccine
- Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems
- Swedish study suggests link between long COVID and severity of illness
- Meta-analysis: Global COVID reinfection rate less than 1%, depending on variant, country, time